Literature DB >> 2157244

Initial clinical results of a 430 MHz microwave hyperthermia system using a lens applicator.

Y Nishimura1, K Akuta, M Hiraoka, S Masunaga, Y Nagata, M Takahashi, M Abe, K Koizumi.   

Abstract

The applicability of a 430 MHz microwave (MW) hyperthermia system using an electric field converging (lens) applicator was evaluated. Twenty-two tumors with a maximum tumor depth of less than 7 cm (10 chest wall tumors, 8 abdominal and pelvic tumors, 2 extremity tumors, and 2 neck tumors) were treated with the lens applicator heating system for a total of 72 sessions in conjunction with irradiation or chemotherapy. Of the 72 heat sessions, our treatment goal of 30 min of hyperthermia with all monitored tumor temperatures above 42 degrees C was achieved in 31 sessions (43%). The average tumor temperature was 42.5, 43.1, 42.0, and 42.0 degrees C for chest wall, abdominal and pelvic, extremity, and neck tumors, respectively; similarly 88, 83, 64 and 50% of monitored points exceeded 41 degrees C. A lens applicator heating system increased the penetration depth of MW, and tumor temperature of 41 degrees C at 5 cm from the surface was easily achieved with a four-aperture lens applicator. Of the 22 tumors, 10 tumors exhibited complete response (CR), 7 partial response (PR) and 5 no response (NR). These results suggest that the lens applicator heating system is useful for heating localized subsurface tumors with a maximum tumor depth of 5-6 cm.

Entities:  

Mesh:

Year:  1990        PMID: 2157244     DOI: 10.1016/0167-8140(90)90206-c

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  2 in total

1.  [A phase-I/II study on the local hyperthermia of cervical N2/N3 lymph node metastases].

Authors:  H Stahl; P Wust; R Graf; J Löffel; J Bier; H Riess; V Jahnke; R Felix
Journal:  Strahlenther Onkol       Date:  1997-04       Impact factor: 3.621

2.  Clinical evaluation of 430 MHz microwave hyperthermia system with lens applicator for cancer therapy.

Authors:  M Hiraoka; Y Nishimura; S Masunaga; M Koishi; M Mitsumori; Y P Li; Y Nagata; K Akuta; M Takahashi; M Abe
Journal:  Med Biol Eng Comput       Date:  1995-01       Impact factor: 2.602

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.